Hennekam–Van der Horst syndrome
Hennekam–Van der Horst syndrome is a rare genetic disorder characterized by a combination of lymphedema, intellectual disability, and facial anomalies. The syndrome is named after the researchers who first described it in the medical literature. This condition is part of a group of diseases known as genetic disorders that are passed down through families.
Symptoms and Characteristics[edit | edit source]
Hennekam–Van der Horst syndrome presents a variety of symptoms, the most notable being:
- Lymphedema: Swelling due to fluid retention and tissue swelling, often noticeable in the limbs.
- Intellectual Disability: Varying degrees of cognitive impairment.
- Facial Anomalies: Distinctive facial features may include a flat nasal bridge, small chin, and widely spaced eyes.
Other possible symptoms can include malformations of the lymphatic system, heart defects, and growth retardation. The severity and combination of symptoms can vary significantly among affected individuals.
Causes[edit | edit source]
The syndrome is caused by mutations in specific genes that are crucial for the development and function of the lymphatic system and cognitive development. These genetic mutations are typically inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder.
Diagnosis[edit | edit source]
Diagnosis of Hennekam–Van der Horst syndrome is based on a combination of clinical evaluation, the presence of characteristic symptoms, and genetic testing. Genetic testing can confirm the presence of mutations in the genes associated with the syndrome, providing a definitive diagnosis.
Treatment[edit | edit source]
There is no cure for Hennekam–Van der Horst syndrome, and treatment focuses on managing symptoms and improving quality of life. Management strategies may include:
- Physical therapy and compression garments for lymphedema.
- Educational support and therapies for intellectual disability.
- Regular monitoring and treatment for heart defects and other associated conditions.
Prognosis[edit | edit source]
The prognosis for individuals with Hennekam–Van der Horst syndrome varies depending on the severity of symptoms and the presence of associated conditions. With appropriate management, individuals can lead fulfilling lives, although they may face challenges related to their symptoms.
Research[edit | edit source]
Ongoing research aims to better understand the genetic basis of Hennekam–Van der Horst syndrome and to develop more effective treatments. Advances in genetic therapy and regenerative medicine hold promise for future interventions.
Hennekam–Van der Horst syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD